SCHEMBL11036951

SCHEMBL11036951

O=C(O)CN1CCCCCCC1=O

nearest known ligand 0.58

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TSHR P16473 1/20 0.58
KMT2A Q03164 2/20 0.56
L3MBTL1 Q9Y468 1/20 0.51
HTT P42858 1/20 0.50
ACE P12821 2/20 0.45
BLM P54132 1/20 0.44
HRH3 Q9Y5N1 1/20 0.44
GAA P10253 1/20 0.43
SMN1; SMN2 Q16637 1/20 0.43
ALDH1A1 P00352 2/20 0.42
CYP1A2 P05177 1/20 0.42
CHRM2 P08172 1/20 0.42
CHRM4 P08173 1/20 0.42
CHRM5 P08912 1/20 0.42
CYP2D6 P10635 1/20 0.42
CHRM1 P11229 1/20 0.42
CYP2C9 P11712 1/20 0.42
CHRM3 P20309 1/20 0.42
CYP2C19 P33261 1/20 0.42
LMNA P02545 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL596327 1.00 TSHR (0.58) TSHRKMT2AL3MBTL1HTTACE
SCHEMBL948880 0.98 TSHR (0.60) TSHRKMT2AL3MBTL1HTTACE
SCHEMBL948990 0.92 TSHR (0.68) TSHRKMT2AHTTACEBLM
SCHEMBL21958786 0.90 TSHR (0.49) TSHRKMT2AL3MBTL1HTTACE
SCHEMBL43400 0.83
SCHEMBL6361223 0.83 TSHR (0.50) TSHRKMT2AHTTACEALDH1A1
SCHEMBL12554864 0.82 TSHR (0.56) TSHRKMT2AL3MBTL1HTTBLM
SCHEMBL1532937 0.82 TSHR (0.85) TSHRKMT2AL3MBTL1HTTBLM
SCHEMBL14828748 0.81 KMT2A (0.53) TSHRKMT2AL3MBTL1HTTBLM
SCHEMBL24263535 0.80 TSHR (0.89) TSHRKMT2AL3MBTL1HTTBLM

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0049842-B1 SUBSTITUTED ENANTHOLACTAM DERIVATIVES, A PROCESS FOR THE PREPARATION AND A PHARMACEUTICAL COMPOSITION USEFUL IN THE TREATMENT OF HYPERTENSION COMPRISING THE SAME, AND INTERMEDIATES MERCK & CO. INC. (US) 1985-08-28 EP disclosed
US-4396616-A DIURETICS, ENZYME INHIBITORS MERCK & CO., INC. (US) 1983-08-02 US disclosed
EP-0049842-A2 Substituted enantholactam derivatives, a process for the preparation and a pharmaceutical composition useful in the treatment of hypertension comprising the same, and intermediates MERCK & CO. INC. (US) 1982-04-21 EP disclosed